Recurrent parotid pseudogout.

J. Rosales Alexander,C. Magro Checa,J. Salvatierra,Mercedes Caba Molina,E. Raya Álvarez

DOI: https://doi.org/10.1093/rheumatology/kes265

2012-12-01

Rheumatology

Abstract:

What problem does this paper attempt to address?

[Estimation of nitrogen concentration in cotton leaf based on canopy reflectance spectra].

Yan Zhu,Hua-bing Wu,Yongchao Tian,Xia Yao,Xiao‐Jun Allen Liu,Zhiguo Zhou,W. Cao

2007-10-01

Abstract:Through analyzing the relationships of nitrogen concentration in cotton leaf under different nitrogen supply levels with canopy multi-spectral reflectance and its derived ratio vegetation index (RVI, rholambda1/rholambda2), normalized difference vegetation index (NDVI, (rho(lambda1) - rho(lambda2))/(rho(lambda1)) + rho(lambda2)) and differential vegetation index (DVI, rho(lambda1) - rho(lambda2)), the sensitive wave bands and prediction functions of cotton leaf nitrogen concentration were worked out. The vegetation index composed of visible region (610, 660, 680 and 710 nm) and near infrared region (760, 810, 870, 950, 1 100 and 1 220 nm) had a higher correlation with the nitrogen concentration in cotton leaf, and the RVI composed of 950 nm and 710 nm could best predict the leaf nitrogen concentration. The validation with independent field experimental data indicated that RVI (950 nm and 710 nm) -based model was suitable for estimation of leaf nitrogen concentration of different cotton cultivars at their different growth stages.
The Role of AI in Drug Discovery

Mohamed Abbas,Abrar Rassam,Rehab Abunora,Fatima Karamshahi,Maha Abouseada

DOI: https://doi.org/10.1002/cbic.202300816

IF: 3.2

2024-05-13

ChemBioChem

Abstract:The emergence of Artificial Intelligence (AI) in drug discovery marks a pivotal shift in pharmaceutical research, blending sophisticated computational techniques with conventional scientific exploration to break through enduring obstacles. This review paper elucidates the multifaceted applications of AI across various stages of drug development, highlighting significant advancements and methodologies. It delves into AI's instrumental role in drug design, polypharmacology, chemical synthesis, drug repurposing, and the prediction of drug properties such as toxicity, bioactivity, and physicochemical characteristics. Despite AI's promising advancements, the paper also addresses the challenges and limitations encountered in the field, including data quality, generalizability, computational demands, and ethical considerations. By offering a comprehensive overview of AI's role in drug discovery, this paper underscores the technology's potential to significantly enhance drug development, while also acknowledging the hurdles that must be overcome to fully realize its benefits.

biochemistry & molecular biology,chemistry, medicinal
Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

Prafulla C. Tiwari,Rishi Pal,Manju J. Chaudhary,Rajendra Nath

DOI: https://doi.org/10.1002/ddr.22115

2023-09-17

Drug Development Research

Abstract:By harnessing artificial intelligence (AI) algorithms and machine learning techniques, the entire drug discovery process stands to undergo a profound transformation, offering a myriad of advantages. Foremost among these is the ability of AI to conduct swift and efficient screenings of expansive compound libraries, significantly augmenting the identification of potential drug candidates. Moreover, AI algorithms can prove instrumental in predicting the efficacy and safety profiles of candidate compounds, thus endowing invaluable insights and reducing reliance on extensive preclinical and clinical testing. This predictive capacity of AI has the potential to streamline the drug development pipeline and enhance the success rate of clinical trials, ultimately resulting in the emergence of more efficacious and safer therapeutic agents. However, the deployment of AI in drug discovery introduces certain challenges that warrant attention. A primary hurdle entails the imperative acquisition of high‐quality and diverse data. Furthermore, ensuring the interpretability of AI models assumes critical importance in securing regulatory endorsement and cultivating trust within scientific and medical communities. Addressing ethical considerations, including data privacy and mitigating bias, represents an additional momentous challenge, requiring assiduous navigation. In this review, we provide an intricate and comprehensive overview of the multifaceted challenges intrinsic to conventional drug development paradigms, while simultaneously interrogating the efficacy of AI in effectively surmounting these formidable obstacles.

pharmacology & pharmacy,chemistry, medicinal
Opposite effects of thiocyanate on tyrosine iodination and thyroid hormone synthesis.

A. Virion,D. Deme,Jacques Pommier,Jacques Nunez

DOI: https://doi.org/10.1111/J.1432-1033.1980.TB04979.X

1980-11-01

European Journal of Biochemistry

Abstract:The effect of a pseudohalide, SCN-, an anion with the same molecular size as iodide, was studied on two reactions: thyroglobulin iodination and thyroid hormone synthesis (coupling reaction) catalyzed by peroxidases. The coupling reaction was studied separately from the iodination reaction by using labelled thyroglobulin samples previously iodinated but containing little or no hormones. 1. SCN- inhibits iodide oxidation (I- leads to I2) whatever the enzyme, thyroid, lactoperoxidase or horseradish peroxidase. The amount of SCN- required to completely inhibit this reaction varies depending on the enzyme. Similarly tyrosine iodination is inhibited by SCN- with large variations, depending on the peroxidase, in the concentration of this anion required for inhibition. 2. In contrast SCN- stimulates the coupling reaction: (a) this affect is seen with the thyroid and lactoperoxidases but not with horseradish peroxidase; (b) the concentration of SCN- required for half-maximal stimulation of the coupling reaction is much lower (0.5-1 microM) than that required for the inhibition of iodide oxidation (60-80 microM); (c) ClO4(-), an anion with the same molecular size as SCN- and I-, has no effect on the coupling reaction; (d) this stimulatory effect of SCN- does not depend on a modification of the thyroglobulin molecule since it is not seen with horseradish peroxidase or in purely chemical coupling conditions. 3. The stimulatory effect of SCN- is therefore seen as resulting from the binding of this anion to a limited number of high-affinity sites present at the surface of both thyroid and lactoperoxidases. The inhibitory effect depends, in contrast, on the binding of SCN- to the substrate site with lower affinities. Since iodide also behaves both as a substrate for the iodination reaction and as a stimulatory ligand for the coupling reaction, these data provide further support in favour of the existence of an enzyme-iodide (or SCN-) complex with catalytic properties different from those of the native peroxidase.
AI approaches for the discovery and validation of drug targets

Aaron Wenteler,Claudia P Cabrera,Wei Wei,Victor Neduva,Michael R Barnes

DOI: https://doi.org/10.1017/pcm.2024.4

2024-05-24

Abstract:Artificial intelligence (AI) holds immense promise for accelerating and improving all aspects of drug discovery, not least target discovery and validation. By integrating a diverse range of biological data modalities, AI enables the accurate prediction of drug target properties, ultimately illuminating biological mechanisms of disease and guiding drug discovery strategies. Despite the indisputable potential of AI in drug target discovery, there are many challenges and obstacles yet to be overcome, including dealing with data biases, model interpretability and generalisability, and the validation of predicted drug targets, to name a few. By exploring recent advancements in AI, this review showcases current applications of AI for drug target discovery and offers perspectives on the future of AI for the discovery and validation of drug targets, paving the way for the generation of novel and safer pharmaceuticals.
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

Ri Han,Hongryul Yoon,Gahee Kim,Hyundo Lee,Yoonji Lee

DOI: https://doi.org/10.3390/ph16091259

IF: 4.6

2023-09-07

Pharmaceuticals

Abstract:Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI's expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI's growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts.

pharmacology & pharmacy,chemistry, medicinal
The Future of ChatGPT in Medicinal Chemistry: Harnessing AI for Accelerated Drug Discovery

Tathagata Pradhan,Ojasvi Gupta,Gita Chawla

DOI: https://doi.org/10.1002/slct.202304359

2024-03-29

ChemistrySelect

Abstract:The Future of ChatGPT in Medicinal Chemistry envisions AI‐driven breakthroughs in drug discovery. Utilizing advanced language models like ChatGPT, accelerates screening and optimization of chemical compounds, predicting their interactions and properties. This synergy of AI and Medicinal Chemistry promises to revolutionize pharmaceutical research. Artificial Intelligence (AI) has emerged as a transformative tool in various fields, including medicinal chemistry and drug discovery. The integration of artificial intelligence (AI) and machine learning (ML) technologies in medicinal chemistry has revolutionized drug discovery processes. Among AI models, ChatGPT (Generative Pre‐trained Transformer) has shown remarkable capabilities in natural language understanding and generation. This review article delves into the potential applications and prospects of ChatGPT in the domain of medicinal chemistry, focusing on its contributions to drug discovery, compound design, virtual screening, target identification, and optimization of pharmacokinetic properties. ChatGPT′s ability to generate contextually relevant text makes it a valuable tool for data mining and analysis of vast chemical and biological information repositories. In this review article, the authors have discussed the challenges and ethical considerations associated with the implementation of ChatGPT 3.5 in medicinal chemistry research. Authors also extend their acknowledgment to ChatGPT (version 3.5) for its contribution in furnishing responses to the prompt, thereby shedding light on the applications of ChatGPT in the field of medicinal chemistry. The authors have analyzed the responses of ChatGPT.

chemistry, multidisciplinary
Artificial Intelligence for Drug Discovery: Are We There Yet?

Catrin Hasselgren,Tudor I. Oprea

DOI: https://doi.org/10.1146/annurev-pharmtox-040323-040828

2023-07-13

Abstract:Drug discovery is adapting to novel technologies such as data science, informatics, and artificial intelligence (AI) to accelerate effective treatment development while reducing costs and animal experiments. AI is transforming drug discovery, as indicated by increasing interest from investors, industrial and academic scientists, and legislators. Successful drug discovery requires optimizing properties related to pharmacodynamics, pharmacokinetics, and clinical outcomes. This review discusses the use of AI in the three pillars of drug discovery: diseases, targets, and therapeutic modalities, with a focus on small molecule drugs. AI technologies, such as generative chemistry, machine learning, and multi-property optimization, have enabled several compounds to enter clinical trials. The scientific community must carefully vet known information to address the reproducibility crisis. The full potential of AI in drug discovery can only be realized with sufficient ground truth and appropriate human intervention at later pipeline stages.

Artificial Intelligence,Machine Learning,Quantitative Methods
Rectal cancer: adjuvant therapy and new directions.

K. Mcmullen,C. Matthews,A. Blackstock

DOI: https://doi.org/10.2174/157488707779318071

Reviews on Recent Clinical Trials

Abstract:Cancers of the colon and rectum are a leading cause of cancer-related death in the United States and worldwide. The 5-year survival rates, in general, have improved over time for patients with colon cancer due to evolving preventative strategies, improved screening techniques and the recent development of more effective therapeutic agents. Unfortunately, the treatment for patients with locally advanced rectal cancer remains less studied. This review will highlight recently reported trials evaluating pre-operative versus post-operative treatment strategies. A discussion of ongoing trials incorporating conventional chemotherapy and radiation will be included as well as trials planned or ongoing that incorporate radiation and the targeted agents. Further work is required regarding the rational integration of these targeted agents and the optimal selection of patients that will most likely benefit.
The potential applications of artificial intelligence in drug discovery and development

H Farghali,N Kutinová Canová,M Arora

DOI: https://doi.org/10.33549/physiolres.934765

2021-12-30

Abstract:Development of a new dug is a very lengthy and highly expensive process since only preclinical, pharmacokinetic, pharmacodynamic and toxicological studies include a multiple of in silico, in vitro, in vivo experimentations that traditionally last several years. In the present review, we briefly report some examples that demonstrate the power of the computer-assisted drug discovery process with some examples that are published and revealing the successful applications of artificial intelligence (AI) technology on this vivid area. Besides, we address the situation of drug repositioning (repurposing) in clinical applications. Yet few success stories in this regard that provide us with a clear evidence that AI will reveal its great potential in accelerating effective new drug finding. AI accelerates drug repurposing and AI approaches are altogether necessary and inevitable tools in new medicine development. In spite of the fact that AI in drug development is still in its infancy, the advancements in AI and machine-learning (ML) algorithms have an unprecedented potential. The AI/ML solutions driven by pharmaceutical scientists, computer scientists, statisticians, physicians and others are increasingly working together in the processes of drug development and are adopting AI-based technologies for the rapid discovery of medicines. AI approaches, coupled with big data, are expected to substantially improve the effectiveness of drug repurposing and finding new drugs for various complex human diseases.
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Dolores R. Serrano,Francis C. Luciano,Brayan J. Anaya,Baris Ongoren,Aytug Kara,Gracia Molina,Bianca I. Ramirez,Sergio A. Sánchez-Guirales,Jesus A. Simon,Greta Tomietto,Chrysi Rapti,Helga K. Ruiz,Satyavati Rawat,Dinesh Kumar,Aikaterini Lalatsa

DOI: https://doi.org/10.3390/pharmaceutics16101328

IF: 6.525

2024-10-15

Pharmaceutics

Abstract:Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advanced computational methods. These innovations have unlocked unprecedented opportunities for the acceleration of drug discovery and delivery, the optimization of treatment regimens, and the improvement of patient outcomes. AI is swiftly transforming the pharmaceutical industry, revolutionizing everything from drug development and discovery to personalized medicine, including target identification and validation, selection of excipients, prediction of the synthetic route, supply chain optimization, monitoring during continuous manufacturing processes, or predictive maintenance, among others. While the integration of AI promises to enhance efficiency, reduce costs, and improve both medicines and patient health, it also raises important questions from a regulatory point of view. In this review article, we will present a comprehensive overview of AI's applications in the pharmaceutical industry, covering areas such as drug discovery, target optimization, personalized medicine, drug safety, and more. By analyzing current research trends and case studies, we aim to shed light on AI's transformative impact on the pharmaceutical industry and its broader implications for healthcare.

pharmacology & pharmacy
Artificial intelligence in drug discovery: recent advances and future perspectives

José Jiménez-Luna,Francesca Grisoni,Nils Weskamp,Gisbert Schneider

DOI: https://doi.org/10.1080/17460441.2021.1909567

2021-04-02

Expert Opinion on Drug Discovery

Abstract:Introduction: Artificial intelligence (AI) has inspired computer-aided drug discovery. The widespread adoption of machine learning, in particular deep learning, in multiple scientific disciplines, and the advances in computing hardware and software, among other factors, continue to fuel this development. Much of the initial skepticism regarding applications of AI in pharmaceutical discovery has started to vanish, consequently benefitting medicinal chemistry.Areas covered: The current status of AI in chemoinformatics is reviewed. The topics discussed herein include quantitative structure-activity/property relationship and structure-based modeling, de novo molecular design, and chemical synthesis prediction. Advantages and limitations of current deep learning applications are highlighted, together with a perspective on next-generation AI for drug discovery.Expert opinion: Deep learning-based approaches have only begun to address some fundamental problems in drug discovery. Certain methodological advances, such as message-passing models, spatial-symmetry-preserving networks, hybrid de novo design, and other innovative machine learning paradigms, will likely become commonplace and help address some of the most challenging questions. Open data sharing and model development will play a central role in the advancement of drug discovery with AI.

pharmacology & pharmacy
The Role of Artificial Intelligence in Drug Discovery and Development

Michael Liebman

DOI: https://doi.org/10.1515/ci-2022-0105

2022-01-01

Chemistry International

Abstract:Abstract Artificial Intelligence (AI) is an exciting, growing field. Due to the high and growing number of data, the comprehensive evaluation of information behind data makes AI tools indispensable. In Drug Discovery and Development the application of AI has become important to accelerate progress and enhance decision making in many fields and disciplines of medicinal chemistry, upscaling, molecular and cell biology, pharmacology, pharmacokinetics, formulation development and toxicology. In clinical testing AI has high importance in increasing success rates by enhancing trial design (biomarkers, efficacy parameters, dose selection, trial duration), selection of the target patient population, patient stratification and evaluation of patient samples. The increasing relevance of AI in drug discovery and development is reflected by the growing number of start-up companies specialized in this field, the growing number of collaborations from Pharma with AI platforms, and the high number of articles and reviews reporting current applications, their success and limitations.
A review on artificial intelligence and machine learning used in pharmaceutical research

Utkarsha A. Wadighare,Swati P. Deshmukh

DOI: https://doi.org/10.30574/gscbps.2024.26.1.0446

2024-01-30

GSC Biological and Pharmaceutical Sciences

Abstract:The cutting-edge upward push of artificial intelligence and system mastering has been of considerable size. It has reduced the human workload move forward exceptional of life exceptionally. This article describes using artificial intelligence and system learning to augment drug discovery and upgrade to lead them to more well organised and correct. In medication, specialties in which images are vitally important, like radiology, pathology or oncology, have seized the able to be done and full-size efforts in studies and development were deployed to switch the adaptness of AI to scientific packages. With AI becoming a extra widespread device for usual scientific imaging evaluation duties, together with prognosis, segmentation, or classification, the important thing for a secure and efficient use of medical AI packages. This body of work supported the jobs of system gaining knowledge of and synthetic intelligence in facilitating drug expansion and finding out methods, making them greater cost-powerful or altogether casting off the want for clinical trials, as a result of the potential to conduct simulations the usage of those technologies. Doing so will assist in separating wish from hype and lead to knowledgeable choice making at the top-quality use of AI/ML in drug development. Machine studying strategies can subterfuge complicated analyzes with huge, heterogeneous, and excessive dimensional information collections without a guide enter, which has proved helpful inside the writing commercial enterprise applications. Combining system mastering, particularly deep getting to know, with human skill and revel in is probably the great manner to coordinate numerous significant facts stores. The magnificent facts-mining capacity of AI innovation has given new essentiality to computer supported medication plans that incorporate more than one clinical concerns are higher than piecemeal data.
Data-centric challenges with the application and adoption of artificial intelligence for drug discovery

Ghita Ghislat,Saiveth Hernandez-Hernandez,Chayanit Piyawajanusorn,Pedro J. Ballester

2024-09-25

Abstract:Introduction: Artificial intelligence (AI) is exhibiting tremendous potential to reduce the massive costs and long timescales of drug discovery. There are however important challenges currently limiting the impact and scope of AI models. Areas covered: In this perspective, the authors discuss a range of data issues (bias, inconsistency, skewness, irrelevance, small size, high dimensionality), how they challenge AI models, and which issue-specific mitigations have been effective. Next, they point out the challenges faced by uncertainty quantification techniques aimed at enhancing and trusting the predictions from these AI models. They also discuss how conceptual errors, unrealistic benchmarks and performance misestimation can confound the evaluation of models and thus their development. Lastly, the authors explain how human bias, whether from AI experts or drug discovery experts, constitutes another challenge that can be alleviated by gaining more prospective experience. Expert opinion: AI models are often developed to excel on retrospective benchmarks unlikely to anticipate their prospective performance. As a result, only a few of these models are ever reported to have prospective value (e.g. by discovering potent and innovative drug leads for a therapeutic target). The authors have discussed what can go wrong in practice with AI for drug discovery. We hope that this will help inform the decisions of editors, funders investors and researchers working in this area.

Other Quantitative Biology
Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Peter Chinedu Agu,Chidiebere Nwiboko Obulose

DOI: https://doi.org/10.1002/ddr.22159

2024-02-21

Drug Development Research

Abstract:The purpose of this study was to discuss how artificial intelligence (AI) methods have affected the field of drug development. It looks at how AI models and data resources are reshaping the drug development process by offering more affordable and expedient options to conventional approaches. The paper opens with an overview of well‐known information sources for drug development. The discussion then moves on to molecular representation techniques that make it possible to convert data into representations that computers can understand. The paper also gives a general overview of the algorithms used in the creation of drug discovery models based on AI. In particular, the paper looks at how AI algorithms might be used to forecast drug toxicity, drug bioactivity, and drug physicochemical properties. De novo drug design, binding affinity prediction, and other AI‐based models for drug–target interaction were covered in deeper detail. Modern applications of AI in nanomedicine design and pharmacological synergism/antagonism prediction were also covered. The potential advantages of AI in drug development are highlighted as the evaluation comes to a close. It underlines how AI may greatly speed up and improve the efficiency of drug discovery, resulting in the creation of new and better medicines. To fully realize the promise of AI in drug discovery, the review acknowledges the difficulties that come with its uses in this field and advocates for more study and development.

pharmacology & pharmacy,chemistry, medicinal
Ethical Issues Arising from the Use of AI in Drug Discovery

Georgia Livieri,Charikleia Anastasopoulou,Konstantina Briola,Panagiota Nikolopoulou,Iris Panagiota Efthymiou

DOI: https://doi.org/10.12681/jpentai.37093

2024-02-29

Abstract:Lately, the pharmaceutical industry has been implementing artificial intelligence (AI) in research in multiple ways for the purpose of drug discovery. AI has great benefits to offer by performing tasks that a human may not be capable of. However, it also raises many ethical issues that need to be resolved. After describing the general picture, this paper explores the benefits and disadvantages of AI and attempts to find answers to the challenges it poses in order to make sure that its use will be ethical, fair, unbiased and beneficial to people. The challenges addressed below focus on ensuring patients’ safety from biased AI algorithms and violation of their data privacy, the need to train and inform staff properly, as well as the necessity of achieving an optimal level of trust towards AI. In the end, some policy recommendations are being presented, aiming to contribute to the centralized approach and to the balanced sense among the uses of AI. The key to success is always taking into account human agency in order to make AI’s use transparent and robust, while minimizing its risks.
Exploring the Artificial Intelligence and Machine Learning Models in the Context of Drug Design Difficulties and Future Potential for the Pharmaceutical Sectors

Periyasamy Natarajan Shiammala,Navaneetha Krishna Bose Duraimutharasan,Baskaralingam Vaseeharan,Abdulaziz S Alothaim,Esam S Al-Malki,Babu Snekaa,Sher Zaman Safi,Sanjeev Kumar Singh,Devadasan Velmurugan,Chandrabose Selvaraj,Abdulaziz S. Alothaim

DOI: https://doi.org/10.1016/j.ymeth.2023.09.010

IF: 4.647

2023-09-01

Methods

Abstract:Artificial intelligence (AI), particularly deep learning as a subcategory of AI, provides opportunities to accelerate and improve the process of discovering and developing new drugs. The use of AI in drug discovery is still in its early stages, but it has the potential to revolutionize the way new drugs are discovered and developed. As AI technology continues to evolve, it is likely that AI will play an even greater role in the future of drug discovery. AI is used to identify new drug targets, design new molecules, and predict the efficacy and safety of potential drugs. The inclusion of AI in drug discovery can screen millions of compounds in a matter of hours, identifying potential drug candidates that would have taken years to find using traditional methods. AI is highly utilized in the pharmaceutical industry by optimizing processes, reducing waste, and ensuring quality control. This review covers much-needed topics, including the different types of machine-learning techniques, their applications in drug discovery, and the challenges and limitations of using machine learning in this field. The state-of-the-art of AI-assisted pharmaceutical discovery is described, covering applications in structure and ligand-based virtual screening, de novo drug creation, prediction of physicochemical and pharmacokinetic properties, drug repurposing, and related topics. Finally, many obstacles and limits of present approaches are outlined, with an eye on potential future avenues for AI-assisted drug discovery and design.

biochemistry & molecular biology,biochemical research methods
Harnessing the Power of AI in Pharmacokinetics and Pharmacodynamics: A Comprehensive Review

Vijaykumar Pawar,Abhinandan Patil,Firoj Tamboli,Dinanath Gaikwad,Dipak Mali,Anilkumar Shinde

DOI: https://doi.org/10.25258/ijpqa.14.2.31

2023-06-25

International Journal of Pharmaceutical Quality Assurance

Abstract:Personalized medicine, medication discovery, and development might all benefit greatly from AI’s incorporation into pharmacokinetics and pharmacodynamics. Target identification, therapeutic effectiveness prediction, drug design optimization, obstacles, and future possibilities are all explored in this survey of AI applications in these areas. An overview of pharmacokinetics and pharmacodynamics is presented first, stressing the significance of knowing how drugs are absorbed, distributed, metabolized, and excreted and the correlation between drug concentration and pharmacological effect. The article then looks into the function of AI in target identification, exploring how machine learning algorithms and data integration may be used to discover new drug targets and enhance the design of existing ones. Classification and regression methods are also investigated for their potential use in the prediction of therapeutic efficacy using AI. Patient data, molecular interaction data, and clinical response data are just a few examples of the types of data that may be used to fuel the creation of predictive models that might assist in dosage and efficacy optimization. Metrics and procedures for validating these models are addressed to evaluate their efficacy. Additionally, de novo drug design, virtual screening, and structure-based drug design are all discussed in relation to the use of AI in optimizing drug development. The paper provides examples of how AI has been applied successfully in different settings, demonstrating its potential to hasten the drug discovery process and enhance treatment outcomes. We examine data availability, interpretability, and ethical implications as challenges and limits of AI in pharmacokinetics and pharmacodynamics. To guarantee these technologies’ proper and ethical use, we also discuss the regulatory elements and rules for applying AI in drug research. Possibilities and prospects for the use of AI in pharmacokinetics and pharmacodynamics are discussed as a conclusion to the review. It stresses the significance of regulatory standards and clinical translation, as well as the incorporation of multiomics data, deep learning methods, real-time monitoring, explainable artificial intelligence, collaborative networks, and more.
Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery

Anita Ioana Visan,Irina Negut

DOI: https://doi.org/10.3390/life14020233

2024-02-08

Life

Abstract:Drug development is expensive, time-consuming, and has a high failure rate. In recent years, artificial intelligence (AI) has emerged as a transformative tool in drug discovery, offering innovative solutions to complex challenges in the pharmaceutical industry. This manuscript covers the multifaceted role of AI in drug discovery, encompassing AI-assisted drug delivery design, the discovery of new drugs, and the development of novel AI techniques. We explore various AI methodologies, including machine learning and deep learning, and their applications in target identification, virtual screening, and drug design. This paper also discusses the historical development of AI in medicine, emphasizing its profound impact on healthcare. Furthermore, it addresses AI's role in the repositioning of existing drugs and the identification of drug combinations, underscoring its potential in revolutionizing drug delivery systems. The manuscript provides a comprehensive overview of the AI programs and platforms currently used in drug discovery, illustrating the technological advancements and future directions of this field. This study not only presents the current state of AI in drug discovery but also anticipates its future trajectory, highlighting the challenges and opportunities that lie ahead.

biology

Recurrent parotid pseudogout.

[Estimation of nitrogen concentration in cotton leaf based on canopy reflectance spectra].

The Role of AI in Drug Discovery

Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges

Opposite effects of thiocyanate on tyrosine iodination and thyroid hormone synthesis.

AI approaches for the discovery and validation of drug targets

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery

The Future of ChatGPT in Medicinal Chemistry: Harnessing AI for Accelerated Drug Discovery

Artificial Intelligence for Drug Discovery: Are We There Yet?

Rectal cancer: adjuvant therapy and new directions.

The potential applications of artificial intelligence in drug discovery and development

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Artificial intelligence in drug discovery: recent advances and future perspectives

The Role of Artificial Intelligence in Drug Discovery and Development

A review on artificial intelligence and machine learning used in pharmaceutical research

Data-centric challenges with the application and adoption of artificial intelligence for drug discovery

Piquing artificial intelligence towards drug discovery: Tools, techniques, and applications

Ethical Issues Arising from the Use of AI in Drug Discovery

Exploring the Artificial Intelligence and Machine Learning Models in the Context of Drug Design Difficulties and Future Potential for the Pharmaceutical Sectors

Harnessing the Power of AI in Pharmacokinetics and Pharmacodynamics: A Comprehensive Review

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery